What is creatine monohydrate used for?
The reference describes two uses for creatine monohydrate:
Increasing body or lean muscle mass or size when used with a resistance-training regimen.
Improving strength, power, or performance during repeated bouts of brief, high-intensity activity, such as sprints, jumping, and resistance training.
The second use includes an explanation involving increased creatine, phosphocreatine, or energy levels within muscle. These descriptions retain the exercise and training conditions in the reference; they are not claims about every activity or every creatine preparation.
Who and which forms does this guide cover?
The information applies to creatine monohydrate taken by mouth by adults aged 18 and older. The reference does not give a dosing plan for children or other forms of creatine.
Foods and food-like products are outside its scope. Liquids and solutions are also excluded because of concerns about the stability of the finished product. These limits matter when comparing a product with the amounts below.
Amounts and duration
The reference provides three separate options. Options 1 and 2 begin with a loading phase, followed by a maintenance phase. Option 3 has no loading phase. They are alternatives, rather than steps to combine.
All amounts below are grams of creatine monohydrate.
| Option | Starting daily amount | Starting duration | Maintenance daily amount |
|---|---|---|---|
| 1, loading, then maintenance | 15–20 g; maximum 5 g in one dose | 5–7 days | 2–5 g |
| 2, loading, then maintenance | 3–5 g | At least 4 weeks | 2–5 g |
| 3, no loading phase | 3–5 g | At least 4 weeks | No separate maintenance phase listed |
Daily amounts and single-dose limits answer different questions. The daily amount is the total for a day; the single-dose maximum applies to one administration. For Option 1, the 5 g limit applies to one loading dose, while 15–20 g is the daily loading amount.
Options 2 and 3 both begin at 3–5 g per day, but their later directions differ. Option 2 identifies a loading phase lasting at least four weeks, followed by 2–5 g per day for maintenance. Option 3 lists at least four weeks at 3–5 g per day, without a separate loading or maintenance phase.
For Option 2, the single-dose maximum is marked “N/A” in the source; no separate figure is supplied. A maximum maintenance duration is not specified for Options 1 or 2. This is a limit of the reference, not an instruction to continue indefinitely.
Product directions may express the amounts as scoops, sachets, or servings instead of grams. The number of units must correspond to the gram amount for that phase. A scoop or serving count is therefore specific to the product. If a product lists more than one option, its directions should identify them as alternatives.
Warnings and precautions
You may gain weight while using creatine monohydrate.
Speak with a healthcare professional before use if you:
Are pregnant or breastfeeding.
Have a kidney disorder.
An omitted warning does not establish an absence of contraindications or side effects. This guide is not a complete review of every possible risk or reason to avoid use.
Preparation details
Ingredient identity, preparation requirements, and other details that define the scope of this guide.
Preparation and source details
The ingredient covered here is creatine monohydrate. Its chemical name in the source is N-(aminoiminomethyl)-N-methylglycine monohydrate. The source lists creatine monohydrate as both its common name and source ingredient.
The source requires finished-product specifications to follow its product quality guidance. The active ingredient must comply with the source ingredient database requirements. These requirements apply in addition to the process-related impurity criteria described below.
Other ingredients must meet the source ingredient database’s restrictions. Manufacturers must establish appropriate storage conditions; the captured reference does not supply a specific storage instruction for consumers.
The source also sets preparation and quality requirements. Process-related impurities in the finished product or raw material must meet the acceptance criteria in the USP creatine reference or another internationally recognized pharmacopoeia.
The USP testing procedures described are specific to creatine monohydrate as a raw material. Alternative testing methods must be assessed against the relevant pharmacopoeia for suitability. These are manufacturing requirements, not a statement that this website has tested or certified a particular product.
The reference requires no additional contraindication or known-adverse-reaction label statements. That describes its labeling requirements; it is not a finding that risks are absent.
Guide change history
Updates to this SupplementSafety.org guide.
Minor updates
Updated guide wording, organization, and source presentation. Added our editorial change history.
Initial release
Initial SupplementSafety.org guide prepared from source reference material.
Validation: Not yet completed. Editorial updates do not constitute clinical validation.
Sources
Source 1: Randomized, double-blind, placebo-controlled human trial
pubmed.ncbi.nlm.nih.gov · Source checked Sep 10, 2026
Population: 19 healthy men experienced in resistance training; 12 weeks of heavy training.
Creatine recipients gained more fat-free mass and muscle-fiber size, and improved strength more, than placebo recipients during training.
Small study limited to trained men. Its loading dose differed from this guide’s dosing options. This summary is based on the abstract.
Source 2: Double-blind, placebo-controlled human trial
pubmed.ncbi.nlm.nih.gov · Source checked Sep 10, 2026
Population: 23 young male participants described as untrained; six days of supplementation.
Combined power output across five repeated cycling tests increased in the creatine group; the placebo group showed no change.
Small, short laboratory study. The abstract gives no exact age range. Results do not establish effects in every sport or over long-term use. This summary is based on the abstract.
Guide scope and dosing reference
This guide organizes source material about uses, preparations, amounts, and precautions. Read the conditions alongside each statement; the information may apply only to particular preparations or populations.
The source document includes supporting references. The study summaries above were checked against the original abstracts. The remaining cited studies have not all been independently assessed for this guide.
- Source document version
- June 28, 2024
- Source captured
- Aug 15, 2026
- Editorial work
- Editorial preparation. Independent clinical review has not been recorded for this guide.
Full citations are available through the link above. Verification is required to open them; reading this guide does not require verification.
Taking a medication too?
Explore our supplement–medication interaction checker. Its coverage and review status are shown with the results; a missing finding does not establish that a combination is safe.